Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 33 (RPS20P33)

Target
RPS20P33
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S20 pseudogene 33 (RPS20P33) is a processed pseudogene derived from the RPS20 gene, which encodes a component of the small (40S) ribosomal subunit. Pseudogenes like RPS20P33 arise from the reverse transcription and genomic integration of RNA transcripts from protein-coding genes but typically lack regulatory elements or contain disabling mutations that prevent them from encoding a functional protein. The human genome contains many ribosomal protein pseudogenes, which reflect the high expression and evolutionary conservation of ribosomal proteins. RPS20P33, as a pseudogene, is not translated into a protein and does not participate in cellular functions or disease processes directly.

Other names
RPS20_16_1416RPS20P33
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not produce functional proteins)
04

Disease associations

None directly associated with diseases (the parent RPS20 gene is linked to some diseases, but not the pseudogene itself)
05

Safety considerations

None (not relevant for pseudogenes)
06

Biomarkers

None (parental ribosomal protein S20 can serve as a biomarker in proteogenomics, but this does not extend to its pseudogenes)

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 33 (RPS20P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 33 (RPS20P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call